Questions a plan sponsor actually asks.
What is Linagliptin and Metformin used for?
Linagliptin and Metformin is a Dipeptidyl Peptidase 4 Inhibitor medication tracked in Medicare Part D.
Is there a generic for Linagliptin and Metformin?
Yes. 12 ANDAs filed at FDA, 4 generic manufacturers currently shipping.
How much does my plan pay for Linagliptin and Metformin?
Across 329 Part D plans, Linagliptin and Metformin averages $10.15/unit (NADAC). Lowest available: $8.44/unit. Highest in distribution: $16.94/unit.
Is Linagliptin and Metformin on the FDA shortage list?
No. Linagliptin and Metformin is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (10 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.